There are multiple key players, including oncology nurses, in the treatment of patients with myelodysplastic syndrome.
It takes a team to treat patients with myelodysplastic syndrome (MDS), explained Nancy Corbitt, BSN, RN, OCN, CRNI, survivorship nurse navigator at the University of Maryland Greenbaum Cancer Center and member of the AAMDS International Foundation.
At the ONS Annual Congress, Corbitt discussed some of the key players in caring for those with MDS. They include the physician, who will discuss diagnosis and treatments, the oncology nurses who often focus on adverse event management, as well as palliative and advanced care planning specialists.
Survival Benefit, Durable Responses Continue at 3 Years With Liso-cel in Second-line LBCL
July 15th 2024Three-year findings from the TRANSFORM trial provide further evidence that liso-cel should be considered as the new standard of care along with other CAR T-cell therapies for patients with primary refractory or relapsed LBCL, an expert said.